DESMOPRESSIN ORAL LYOPHILISATE (Noqdirna ®)
Clinical Indication
Symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults
Comments
To be started in primary care only. Please click drug name for more information.
Local guidance
Expert opinion in UHL is that all patients should have U+ E checked beforehand and monitored afterwards. NICE and the manufacturer provides extra monitoring requirements for those 65 years and over. Please note doses are lower for women due to increased risk of hyponatraemia.
Date of classification
February 2019
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.